aminolevulinic acid has been researched along with Facial Dermatoses in 79 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Facial Dermatoses: Skin diseases involving the FACE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Photodynamic therapy (PDT) and chemical peels with trichloroacetic acid (TCA) can be applied to large skin areas and thus are suitable treatment options for patients with multiple actinic keratosis (AK)." | 9.24 | Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis. ( Holzer, G; Pinkowicz, A; Radakovic, S; Schmidt, JB; Tanew, A, 2017) |
| "Photodynamic therapy (PDT) and imiquimod are two excellent treatments for actinic keratosis but are often not well tolerated by patients." | 9.15 | A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate. ( Botella-Estrada, R; Guillen, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillen, C, 2011) |
| "To evaluate the safety and efficacy of topical aminolevulinic acid (ALA) photodynamic therapy (PDT) in the treatment of verruca planae." | 7.76 | Efficacy of topical aminolevulinic acid photodynamic therapy for the treatment of verruca planae. ( He, Y; Lu, YG; Wu, JJ; Yang, HZ; Yang, YD, 2010) |
| "Acne vulgaris is a chronic inflammatory skin disease, commonly treated with topical or systemic drugs, according to the severity of the condition." | 6.90 | The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study. ( Bianchi, L; Campione, E; Cannizzaro, MV; Dattola, A; Del Duca, E; Garofalo, V; Milani, M; Serini, SM; Ventura, A, 2019) |
| "Photodynamic therapy (PDT) and chemical peels with trichloroacetic acid (TCA) can be applied to large skin areas and thus are suitable treatment options for patients with multiple actinic keratosis (AK)." | 5.24 | Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis. ( Holzer, G; Pinkowicz, A; Radakovic, S; Schmidt, JB; Tanew, A, 2017) |
| " Objective and visual erythema, protoporphyrin IX (PpIX) fluorescence and pain were evaluated." | 5.19 | Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial. ( Petersen, B; Wiegell, SR; Wulf, HC, 2014) |
| " Aminolevulinic acid (ALA)-PDT for the treatment of actinic keratosis (AK) has been well studied in Europe and North America." | 5.17 | Photodynamic therapy for facial actinic keratosis: a clinical and histological study in Chinese patients. ( Cai, H; Li, Q; Liu, W; Liu, XY; Qiao, L; Sun, P; Tian, R; Wang, YX; Yang, ZY, 2013) |
| "Photodynamic therapy (PDT) and imiquimod are two excellent treatments for actinic keratosis but are often not well tolerated by patients." | 5.15 | A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate. ( Botella-Estrada, R; Guillen, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillen, C, 2011) |
| "To evaluate the safety and efficacy of topical aminolevulinic acid (ALA) photodynamic therapy (PDT) in the treatment of verruca planae." | 3.76 | Efficacy of topical aminolevulinic acid photodynamic therapy for the treatment of verruca planae. ( He, Y; Lu, YG; Wu, JJ; Yang, HZ; Yang, YD, 2010) |
| "The safety and efficacy of treating individuals who presented with multiple actinic keratosis (AK) lesions with 5-aminolevulinic acid (ALA) in combination with photodynamic therapy (PDT) were documented in a phase III trial." | 3.71 | Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment. ( Fowler, JF; Zax, RH, 2002) |
| "The safety and efficacy of treating individuals who presented with multiple actinic keratosis (AK) lesions with 5-aminolevulinic acid (ALA) in combination with photodynamic therapy (PDT) were documented in a phase III trial." | 3.71 | The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging. ( Gold, MH, 2002) |
| "We present the kinetics of ALA-induced protoporphyrin IX (PP) accumulation and the results of ALA PDT treatment on two patients with different stages (stage I and stage III) of mycosis fungoides (MF)-type cutaneous T-cell lymphoma (CTCL)." | 3.70 | Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. ( Haik, J; Kostenich, G; Malik, Z; Orenstein, A; Tamir, J; Trau, H; Winkler, E, 2000) |
| "Pain was evaluated on a scale from 0 to 10." | 2.94 | A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: Bilaterally controlled, randomized trial of simultaneous versus conventional illumination. ( Bullock, T; Hu, B; Ilyas, M; Kaw, U; Maytin, EV; Riha, M; Rittwage, L; Vidimos, A; Warren, CB, 2020) |
| "Acne vulgaris is a chronic inflammatory skin disease, commonly treated with topical or systemic drugs, according to the severity of the condition." | 2.90 | The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study. ( Bianchi, L; Campione, E; Cannizzaro, MV; Dattola, A; Del Duca, E; Garofalo, V; Milani, M; Serini, SM; Ventura, A, 2019) |
| "Severe acne vulgaris has limited therapeutic options." | 2.82 | Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study. ( Bukhalo, M; Eichenfield, LF; Jarratt, M; Pariser, DM; Waterman, G, 2016) |
| "Pain was low and manageable by briefly pausing illumination." | 2.82 | Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study. ( Bukhalo, M; Eichenfield, LF; Jarratt, M; Pariser, DM; Waterman, G, 2016) |
| "Aminolevulinic acid or VEH was applied to face or scalp as a broad area application for 1, 2, or 3 hours or as a spot application for 2 hours before blue light activation." | 2.82 | Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp. ( Berg, JE; Ferdon, MB; Houlihan, A; Pariser, DM, 2016) |
| "However, pain is a major side-effect of this therapy." | 2.80 | Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial. ( Graf, B; Gruber, M; Hansen, E; Heinlin, J; Horner, C; Karrer, S; Kerscher, C; Klein, A; Koller, M; Landthaler, M; Szeimies, RM; Werner, A; Zeman, F, 2015) |
| "Maximum pain was evaluated by means of a visual analogue scale (VAS) during and up to 300 min after PDT." | 2.80 | Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial. ( Graf, B; Gruber, M; Hansen, E; Heinlin, J; Horner, C; Karrer, S; Kerscher, C; Klein, A; Koller, M; Landthaler, M; Szeimies, RM; Werner, A; Zeman, F, 2015) |
| "The main side-effects of PDT are post-treatment erythema and oedema, and pain during illumination." | 2.79 | Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial. ( Petersen, B; Wiegell, SR; Wulf, HC, 2014) |
| "Pain was measured using a visual analog scale immediately and 8 h after PDT." | 2.78 | Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis. ( Enk, AH; Gholam, P; Kroehl, V, 2013) |
| "Aminolevulinic acid (ALA)-PDT for the treatment of actinic keratosis (AK) has been well studied in Europe and North America." | 2.78 | Photodynamic therapy for facial actinic keratosis: a clinical and histological study in Chinese patients. ( Cai, H; Li, Q; Liu, W; Liu, XY; Qiao, L; Sun, P; Tian, R; Wang, YX; Yang, ZY, 2013) |
| "The response rate of Bowen's disease to MAL-PDT is also at least equivalent to cryotherapy and 5-fluorouracil, again with superior cosmesis." | 2.44 | Methyl aminolevulinate: actinic keratoses and Bowen's disease. ( Morton, CA, 2007) |
| "Pain was assessed after the PDT session and local adverse events 2 days after treatment." | 1.42 | Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy. ( Fargnoli, MC; Neri, L; Pellegrini, C; Peris, K; Piccioni, A; Tambone, S, 2015) |
| "46%; RR = 0." | 1.42 | Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy. ( Fargnoli, MC; Neri, L; Pellegrini, C; Peris, K; Piccioni, A; Tambone, S, 2015) |
| "Acne vulgaris is a common dermatological disorder." | 1.37 | Successful treatment of refractory facial acne using repeat short-cycle ALA-PDT: Case study. ( Ding, HL; Huang, Z; Wang, HW; Wang, XL, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.27) | 18.2507 |
| 2000's | 20 (25.32) | 29.6817 |
| 2010's | 57 (72.15) | 24.3611 |
| 2020's | 1 (1.27) | 2.80 |
| Authors | Studies |
|---|---|
| Kaw, U | 1 |
| Ilyas, M | 1 |
| Bullock, T | 1 |
| Rittwage, L | 1 |
| Riha, M | 1 |
| Vidimos, A | 1 |
| Hu, B | 1 |
| Warren, CB | 1 |
| Maytin, EV | 1 |
| Togsverd-Bo, K | 1 |
| Halldin, C | 1 |
| Sandberg, C | 3 |
| Gonzalez, H | 1 |
| Wennberg, AM | 2 |
| Sørensen, SS | 1 |
| Wulf, HC | 7 |
| Haedersdal, M | 4 |
| Fargnoli, MC | 3 |
| Ibbotson, SH | 1 |
| Hunger, RE | 1 |
| Rostain, G | 1 |
| Gaastra, MTW | 1 |
| Eibenschutz, L | 1 |
| Cantisani, C | 1 |
| Venema, AW | 2 |
| Medina, S | 1 |
| Kerrouche, N | 5 |
| Pérez-Garcia, B | 3 |
| Serini, SM | 1 |
| Cannizzaro, MV | 1 |
| Dattola, A | 1 |
| Garofalo, V | 1 |
| Del Duca, E | 1 |
| Ventura, A | 1 |
| Milani, M | 1 |
| Campione, E | 1 |
| Bianchi, L | 1 |
| Slape, DR | 1 |
| Kim, EN | 1 |
| Weller, P | 1 |
| Gupta, M | 1 |
| Vicentini, C | 1 |
| Vignion-Dewalle, AS | 1 |
| Thecua, E | 1 |
| Lecomte, F | 1 |
| Maire, C | 1 |
| Deleporte, P | 1 |
| Béhal, H | 1 |
| Kerob, D | 3 |
| Duhamel, A | 1 |
| Mordon, S | 1 |
| Mortier, L | 1 |
| Willey, A | 1 |
| Karrer, S | 2 |
| Aschoff, RAG | 1 |
| Dominicus, R | 1 |
| Krähn-Senftleben, G | 1 |
| Gauglitz, GG | 1 |
| Zarzour, A | 1 |
| Chavda, R | 1 |
| Szeimies, RM | 3 |
| Shive, ML | 1 |
| Coakley, BJ | 1 |
| Bierman, DF | 1 |
| Serowka Lane, KL | 1 |
| Wiegell, SR | 6 |
| Zachary, CB | 1 |
| Borgia, F | 1 |
| Coppola, M | 1 |
| Giuffrida, R | 1 |
| Cannavò, SP | 1 |
| Jordan, M | 1 |
| Ghoreschi, K | 1 |
| Eberle, FC | 1 |
| Song, W | 1 |
| Zhang, J | 1 |
| Gao, N | 1 |
| Tan, W | 1 |
| Wang, G | 1 |
| Gao, L | 1 |
| Zheng, Z | 1 |
| Zhang, LL | 1 |
| Shi, L | 1 |
| Zhang, YF | 1 |
| Wang, B | 1 |
| Wu, QQ | 1 |
| Fang, F | 1 |
| Wang, WQ | 1 |
| Sroka, R | 1 |
| Wang, XL | 2 |
| Gholam, P | 1 |
| Kroehl, V | 1 |
| Enk, AH | 1 |
| Cai, H | 1 |
| Wang, YX | 1 |
| Sun, P | 1 |
| Yang, ZY | 1 |
| Tian, R | 1 |
| Liu, XY | 1 |
| Li, Q | 1 |
| Qiao, L | 1 |
| Liu, W | 1 |
| Zane, C | 3 |
| Facchinetti, E | 1 |
| Rossi, MT | 1 |
| Specchia, C | 1 |
| Calzavara-Pinton, PG | 1 |
| Rubel, DM | 2 |
| Spelman, L | 3 |
| Murrell, DF | 3 |
| See, JA | 3 |
| Hewitt, D | 3 |
| Foley, P | 3 |
| Bosc, C | 1 |
| Shumack, S | 3 |
| Petersen, B | 2 |
| Neittaanmäki-Perttu, N | 1 |
| Karppinen, TT | 1 |
| Grönroos, M | 1 |
| Tani, TT | 1 |
| Snellman, E | 1 |
| Debu, A | 1 |
| Girard, C | 3 |
| Bessis, D | 1 |
| Klein, A | 1 |
| Horner, C | 1 |
| Werner, A | 1 |
| Heinlin, J | 1 |
| Zeman, F | 1 |
| Koller, M | 1 |
| Landthaler, M | 1 |
| Gruber, M | 1 |
| Graf, B | 1 |
| Hansen, E | 1 |
| Kerscher, C | 1 |
| Berman, B | 1 |
| Nestor, MS | 1 |
| Newburger, J | 1 |
| Park, H | 1 |
| Swenson, N | 1 |
| Piccioni, A | 2 |
| Neri, L | 2 |
| Tambone, S | 2 |
| Pellegrini, C | 2 |
| Peris, K | 2 |
| Rubel, D | 1 |
| Salmon, R | 3 |
| Pascual, T | 1 |
| Fernandez-Penas, P | 2 |
| Lacour, JP | 2 |
| Ulrich, C | 1 |
| Gilaberte, Y | 1 |
| Von Felbert, V | 1 |
| Basset-Seguin, N | 2 |
| Dreno, B | 2 |
| Redondo, P | 1 |
| Serra-Guillen, C | 2 |
| Synnerstad, I | 1 |
| Tarstedt, M | 2 |
| Tsianakas, A | 1 |
| Kelleners-Smeets, N | 1 |
| Adamski, H | 2 |
| Gerritsen, MJ | 1 |
| Leclerc, S | 1 |
| Pariser, DM | 3 |
| Eichenfield, LF | 1 |
| Bukhalo, M | 1 |
| Waterman, G | 1 |
| Jarratt, M | 2 |
| Genovese, G | 1 |
| Fai, D | 1 |
| Fai, C | 1 |
| Mavilia, L | 1 |
| Mercuri, SR | 1 |
| Gao, J | 1 |
| Shen, C | 1 |
| Ko, R | 1 |
| Zheng, X | 1 |
| Wang, Z | 1 |
| Liu, S | 1 |
| Li, Y | 1 |
| Tang, M | 1 |
| Yin, W | 1 |
| Yang, C | 1 |
| Zhang, X | 1 |
| O'Gorman, SM | 1 |
| Clowry, J | 1 |
| Manley, M | 1 |
| McCavana, J | 1 |
| Gray, L | 1 |
| Kavanagh, A | 1 |
| Lally, A | 1 |
| Collins, P | 1 |
| Dessinioti, C | 1 |
| Masouri, S | 1 |
| Drakaki, E | 1 |
| Katsambas, A | 1 |
| Antoniou, C | 1 |
| Houlihan, A | 2 |
| Ferdon, MB | 2 |
| Berg, JE | 1 |
| Beaulieu, P | 1 |
| Riboulet, JL | 1 |
| Moggio, E | 1 |
| Arisi, M | 2 |
| Calzavara-Pinton, I | 1 |
| Calzavara-Pinton, P | 2 |
| Fabiano, A | 1 |
| Paci, K | 1 |
| Bell, RT | 1 |
| Goldstein, B | 1 |
| Lev-Tov, H | 1 |
| Larsen, L | 1 |
| Zackria, R | 1 |
| Chahal, H | 1 |
| Eisen, DB | 1 |
| Sivamani, RK | 1 |
| Holzer, G | 1 |
| Pinkowicz, A | 1 |
| Radakovic, S | 1 |
| Schmidt, JB | 1 |
| Tanew, A | 1 |
| Shokeen, D | 1 |
| Pariser, D | 1 |
| Loss, R | 1 |
| Abramovits, W | 1 |
| Spencer, J | 1 |
| Geronemus, R | 1 |
| Bailin, P | 1 |
| Bruce, S | 1 |
| Lin, MY | 1 |
| Xiang, LH | 1 |
| Fernández-Guarino, M | 2 |
| Harto, A | 2 |
| Sánchez-Ronco, M | 1 |
| Marquet, A | 1 |
| Jaén, P | 2 |
| Kleinpenning, MM | 1 |
| van de Kerkhof, PC | 1 |
| Gerritsen, RM | 1 |
| Lu, YG | 1 |
| Wu, JJ | 1 |
| He, Y | 1 |
| Yang, HZ | 1 |
| Yang, YD | 1 |
| Clementoni, MT | 1 |
| B-Roscher, M | 1 |
| Munavalli, GS | 1 |
| Xi, Z | 1 |
| Shuxian, Y | 1 |
| Zhong, L | 1 |
| Hui, Q | 1 |
| Yan, W | 1 |
| Huilin, D | 1 |
| Leihong, X | 1 |
| Gold, MH | 3 |
| Nagore, E | 1 |
| Hueso, L | 1 |
| Llombart, B | 1 |
| Requena, C | 1 |
| Sanmartín, O | 1 |
| Botella-Estrada, R | 1 |
| Guillen, C | 1 |
| García-Morales, I | 1 |
| Fabricius, S | 2 |
| Stender, IM | 2 |
| Berne, B | 3 |
| Kroon, S | 2 |
| Andersen, BL | 2 |
| Mørk, C | 2 |
| Jemec, GB | 2 |
| Mogensen, M | 1 |
| Brocks, KM | 2 |
| Philipsen, PA | 3 |
| Heydenreich, J | 2 |
| Tyrrell, JS | 1 |
| Morton, C | 2 |
| Campbell, SM | 1 |
| Curnow, A | 1 |
| Penrose, C | 1 |
| Mercer, SE | 1 |
| Shim-Chang, H | 1 |
| Burtica, EC | 1 |
| Magnano, M | 1 |
| Loi, C | 1 |
| Bardazzi, F | 1 |
| Patrizi, A | 1 |
| Tran, DT | 1 |
| Ding, HL | 1 |
| Wang, HW | 1 |
| Huang, Z | 1 |
| Gomes, J | 1 |
| Ventura, F | 1 |
| da Luz Duarte, M | 1 |
| Brito, C | 1 |
| Gniadecka, M | 1 |
| Ibler, KS | 1 |
| Hædersdal, M | 1 |
| Park, KY | 1 |
| Kim, HK | 1 |
| Li, K | 1 |
| Kim, BJ | 1 |
| Seo, SJ | 1 |
| Kim, MN | 1 |
| Hong, CK | 1 |
| Hadley, J | 1 |
| Tristani-Firouzi, P | 1 |
| Hull, C | 1 |
| Florell, S | 1 |
| Cotter, M | 1 |
| Hadley, M | 1 |
| Sanclemente, G | 1 |
| Correa, LA | 1 |
| Garcia, JJ | 1 |
| Barrera, M | 1 |
| Villa, JF | 1 |
| Garcia, HI | 1 |
| Horio, T | 1 |
| Horio, O | 1 |
| Miyauchi-Hashimoto, H | 1 |
| Ohnuki, M | 1 |
| Isei, T | 1 |
| Mizuki, D | 1 |
| Kaneko, T | 1 |
| Hanada, K | 1 |
| Touma, D | 1 |
| Yaar, M | 1 |
| Whitehead, S | 1 |
| Konnikov, N | 1 |
| Gilchrest, BA | 1 |
| Piacquadio, DJ | 1 |
| Chen, DM | 1 |
| Farber, HF | 1 |
| Fowler, JF | 2 |
| Glazer, SD | 1 |
| Goodman, JJ | 1 |
| Hruza, LL | 1 |
| Jeffes, EW | 1 |
| Ling, MR | 1 |
| Phillips, TJ | 1 |
| Rallis, TM | 1 |
| Scher, RK | 1 |
| Taylor, CR | 1 |
| Weinstein, GD | 1 |
| Zakhary, K | 1 |
| Ellis, DA | 1 |
| Rosdahl, I | 1 |
| Svanberg, K | 1 |
| Bradshaw, VL | 1 |
| Boring, MM | 1 |
| Bridges, TM | 1 |
| Biron, JA | 1 |
| Campbell, S | 1 |
| Gupta, G | 1 |
| Keohane, S | 1 |
| Lear, J | 1 |
| Zaki, I | 1 |
| Walton, S | 1 |
| Thomas, G | 1 |
| Soto, P | 1 |
| Tschen, EH | 1 |
| Wong, DS | 1 |
| Dunlap, FE | 1 |
| Richey, DF | 1 |
| Morton, CA | 1 |
| Hohwy, T | 1 |
| Andersen, KE | 1 |
| Sølvsten, H | 1 |
| Sommerlund, M | 1 |
| Eriksen, P | 1 |
| Enk, CD | 1 |
| Orenstein, A | 2 |
| Kostenich, G | 2 |
| Tsur, H | 1 |
| Kogan, L | 1 |
| Malik, Z | 2 |
| Haik, J | 1 |
| Tamir, J | 1 |
| Winkler, E | 1 |
| Trau, H | 1 |
| Itoh, Y | 1 |
| Ninomiya, Y | 1 |
| Henta, T | 1 |
| Tajima, S | 1 |
| Ishibashi, A | 1 |
| Zax, RH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT02520700] | 22 participants (Actual) | Interventional | 2013-09-30 | Completed | |||
| Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization - Clinical and Histopathological Analysis[NCT03013647] | 20 participants (Anticipated) | Interventional | 2016-09-30 | Recruiting | |||
| Topical Imiquimod 5% Cream Therapy Versus Photodynamic Therapy With Methyl-aminolaevulinate 16% Cream of Actinic Keratoses in Organ Transplant Recipients[NCT01538901] | Phase 4 | 10 participants (Actual) | Interventional | 2012-09-30 | Terminated (stopped due to prolonged recruitment phase) | ||
| Indoor Daylight Photo Dynamic Therapy (PDT) for Actinic Keratosis[NCT03805737] | 43 participants (Actual) | Interventional | 2019-11-01 | Completed | |||
| Portable Measurement of Protoporphyrin IX in the Skin[NCT04223570] | 218 participants (Anticipated) | Observational | 2022-12-01 | Enrolling by invitation | |||
| A Clinical Trial of ALA Photodynamic Therapy for Treatment of Actinic Cheilitis in Patients With Squamous Cell Carcinoma of the Lip.[NCT00868088] | Phase 4 | 34 participants (Anticipated) | Interventional | 2009-07-31 | Completed | ||
| A Randomized Half-side Comparative Trial of Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic Therapy in Organ Transplant Recipients With Multiple Actinic Keratoses of the Scalp or Forehead[NCT01898936] | 12 participants (Actual) | Interventional | 2013-08-31 | Completed | |||
| Evaluation of the Formulation of 5-aminolevulinic Acid With Dimethylsulfoxide in Photodynamic Therapy for Treatment of Actinic Keratosis[NCT01459393] | Phase 3 | 137 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for aminolevulinic acid and Facial Dermatoses
| Article | Year |
|---|---|
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
Topics: Aminolevulinic Acid; Australia; Consensus; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Ma | 2016 |
Applications of aminolevulinic Acid-based photodynamic therapy in cosmetic facial plastic practices.
Topics: Aminolevulinic Acid; Cosmetic Techniques; Facial Dermatoses; Humans; Photochemotherapy; Photosensiti | 2005 |
Aminolevulinic acid photodynamic therapy for sebaceous gland hyperplasia.
Topics: Aminolevulinic Acid; Facial Dermatoses; Humans; Hyperplasia; Photochemotherapy; Photosensitizing Age | 2007 |
Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Topics: Aminolevulinic Acid; Bowen's Disease; Facial Dermatoses; Humans; Keratosis; Photochemotherapy; Photo | 2007 |
39 trials available for aminolevulinic acid and Facial Dermatoses
| Article | Year |
|---|---|
A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: Bilaterally controlled, randomized trial of simultaneous versus conventional illumination.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Administration Schedule; Facial Dermatoses; Femal | 2020 |
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Topics: Aged; Aminolevulinic Acid; Drug Eruptions; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imiqu | 2018 |
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study.
Topics: Acne Vulgaris; Adolescent; Adult; Aminolevulinic Acid; Facial Dermatoses; Female; Gels; Humans; Male | 2019 |
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight p
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Forehead; Humans; Keratosis | 2019 |
Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Edema; Erythema; Facial Dermatoses; Female; Humans; Ke | 2013 |
Photodynamic therapy for facial actinic keratosis: a clinical and histological study in Chinese patients.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; China; Facial Dermatoses; Female; Humans; Keratosis, A | 2013 |
A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cost-Benefit Analysis; Diclofenac; Drug Combina | 2014 |
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; | 2014 |
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; C | 2014 |
Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Facial Dermatoses; Female; Humans | 2014 |
Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Analgesia; Analgesics, Opioid; Analysis of Variance | 2015 |
Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Topics: Administration, Cutaneous; Adult; Aminolevulinic Acid; Dermatologic Agents; Diterpenes; Facial Derma | 2014 |
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Europe; Facial Dermatoses; Female; Humans; Keratosis, | 2015 |
Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aminolevulinic Acid; Child; Double-Blin | 2016 |
Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dermatologic Agents; Diterpenes; Facial Dermatoses; Fe | 2016 |
Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Follow-Up Studies; Humans; Keratosi | 2016 |
Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Erythema; Facial Dermatoses; Female; Fluorescence; Hum | 2016 |
Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Erythema; Facial Dermatoses; Female; Humans; Ke | 2016 |
A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Dose-Response Relationship, Drug; Dose-Res | 2016 |
A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Face; Facial Derm | 2016 |
Microneedle-assisted incubation during aminolaevulinic acid photodynamic therapy of actinic keratoses: a randomized controlled evaluator-blind trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Equipment Design; Facial Dermatoses; Female; Forehead; | 2017 |
Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Caustics; Facial Dermatoses; Female; Humans; Keratosis | 2017 |
Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; F | 2008 |
Topical 5-aminolevulinic acid with intense pulsed light versus intense pulsed light for photodamage in Chinese patients.
Topics: Administration, Topical; Adult; Aminolevulinic Acid; China; Double-Blind Method; Facial Dermatoses; | 2011 |
A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminolevulinic Acid; Aminoquinolines; Child; Child, | 2011 |
[Photodynamic therapy for acne: use of the pulsed dye laser and methylaminolevulinate].
Topics: Acne Vulgaris; Adolescent; Aminolevulinic Acid; Combined Modality Therapy; Facial Dermatoses; Female | 2010 |
A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Facial Dermatos | 2011 |
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluo | 2011 |
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluo | 2011 |
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluo | 2011 |
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluo | 2011 |
Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Facial Dermatos | 2012 |
Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Facial Dermatoses; Humans; Imiquimod; | 2012 |
Methyl aminolevulinate plus red light vs. placebo plus red light in the treatment of photodamaged facial skin: histopathological findings.
Topics: Adult; Aged; Aminolevulinic Acid; Collagen; Double-Blind Method; Elastic Tissue; Face; Facial Dermat | 2012 |
A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.
Topics: Administration, Topical; Adult; Aged; Aminolevulinic Acid; Anesthetics, Local; Facial Dermatoses; Fe | 2004 |
Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Fem | 2004 |
A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Keratosis; Ma | 2005 |
Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage.
Topics: Adult; Aminolevulinic Acid; Facial Dermatoses; Female; Follow-Up Studies; Humans; Male; Middle Aged; | 2006 |
Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Cryosurgery; Esthetics; Facial Dermatoses; Female; Hum | 2006 |
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Fem | 2006 |
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Fem | 2006 |
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Fem | 2006 |
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Fem | 2006 |
Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Drug; Facial Dermatoses; F | 2008 |
Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Arm; Asian People; Carcinoma, Squamous Cell; Facial De | 2000 |
36 other studies available for aminolevulinic acid and Facial Dermatoses
| Article | Year |
|---|---|
Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Attitude of Health Personnel; Europe; Facial De | 2018 |
Leishmania tropica successfully treated with photodynamic therapy.
Topics: Adult; Aminolevulinic Acid; Facial Dermatoses; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; | 2019 |
Thermal Photodynamic Therapy for Actinic Keratoses on Facial Skin: A Proof-of-Concept Study.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Hot Temp | 2019 |
Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Germany; Humans; Keratosis, | 2019 |
Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
Topics: Aminolevulinic Acid; Facial Dermatoses; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitiz | 2019 |
Excellent cosmetic result of daylight photodynamic therapy for facial flat warts in a child.
Topics: Aminolevulinic Acid; Child; Esthetics; Facial Dermatoses; Female; Humans; Photochemotherapy; Photose | 2019 |
Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Keratosis, Actinic; | 2019 |
A combination of 2940-nm laser and photodynamic therapy for treatment of recalcitrant facial flat warts.
Topics: Adult; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Laser Therapy; Lasers, Solid-State; M | 2019 |
What is the most relevent factor causing pain during ALA-PDT? A multi-center, open clinical pain score research trial of actinic keratosis, acne and condylomata acuminata.
Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Condylomata Acuminata; Dermoscopy; Facial Dermatoses; Fem | 2019 |
Discoid lupus erythematosus successfully treated by photodynamic therapy.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Facial Dermatoses; Humans; Lupus Erythematosus | 2015 |
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Italy; Keratosis, A | 2015 |
Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
Topics: Aminolevulinic Acid; Australia; Facial Dermatoses; Humans; Keratosis, Actinic; Meteorology; Photoche | 2016 |
Combination effect of super pulsed carbon dioxide laser and photodynamic therapy for recalcitrant facial flat warts: A preliminary study.
Topics: Adolescent; Adult; Aminolevulinic Acid; Combined Modality Therapy; Facial Dermatoses; Female; Humans | 2016 |
Short-contact, low-dose methyl aminolaevulinate photodynamic therapy for acne vulgaris.
Topics: Acne Vulgaris; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Male; Photochemotherapy; Phot | 2016 |
[Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
Topics: Aminolevulinic Acid; Clinical Protocols; Facial Dermatoses; Humans; Keratosis, Actinic; Pain; Patien | 2016 |
Fingernail photo-onycholysis after aminolevulinic acid-photodynamic therapy under blue light for treatment of actinic keratoses on the face.
Topics: Aged; Aminolevulinic Acid; Facial Dermatoses; Female; Fingers; Humans; Keratosis, Actinic; Onycholys | 2016 |
Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
Topics: Aminolevulinic Acid; Facial Dermatoses; Follow-Up Studies; Humans; Keratosis, Actinic; Photochemothe | 2017 |
Update on new drugs in dermatology.
Topics: Aminolevulinic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agent | 2016 |
Topical 5-aminolevulinic acid photodynamic therapy for recalcitrant facial flat wart in Chinese subjects.
Topics: Adolescent; Adult; Aminolevulinic Acid; Asian People; Facial Dermatoses; Female; Humans; Male; Photo | 2008 |
[Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging].
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; | 2008 |
The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Carcino | 2010 |
Efficacy of topical aminolevulinic acid photodynamic therapy for the treatment of verruca planae.
Topics: Administration, Topical; Adolescent; Adult; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; | 2010 |
Photodynamic photorejuvenation of the face with a combination of microneedling, red light, and broadband pulsed light.
Topics: Aged; Aminolevulinic Acid; Cohort Studies; Combined Modality Therapy; Facial Dermatoses; Female; Hum | 2010 |
Photodynamic therapy for the treatment of cutaneous sarcoidosis.
Topics: Aminolevulinic Acid; Black or African American; Esthetics; Facial Dermatoses; Female; Follow-Up Stud | 2011 |
Photodynamic therapy with 5-methylaminolevulinic acid in the treatment of multiple warts of the face.
Topics: Aminolevulinic Acid; Facial Dermatoses; Humans; Male; Photochemotherapy; Photosensitizing Agents; Tr | 2013 |
Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Humans; Keratosis, Actinic; | 2011 |
Successful treatment of refractory facial acne using repeat short-cycle ALA-PDT: Case study.
Topics: Acne Vulgaris; Aminolevulinic Acid; Chronic Disease; Facial Dermatoses; Humans; Male; Photochemother | 2011 |
Colloid milium successfully treated with MAL-PDT.
Topics: Aminolevulinic Acid; Colloids; Facial Dermatoses; Humans; Male; Middle Aged; Photochemotherapy; Phot | 2013 |
Photodynamic therapy: new treatment for refractory lymphocytic infiltration of the skin.
Topics: Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Lymphocytosis; Middle Aged; Photochemotherap | 2012 |
Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolaevulinic acid and slide projector.
Topics: Aminolevulinic Acid; Facial Dermatoses; Humans; Hyperplasia; Male; Middle Aged; Photochemotherapy; P | 2003 |
Successful treatment of topical photodynamic therapy using 5-aminolevulinic acid for plane warts.
Topics: Adolescent; Aminolevulinic Acid; Facial Dermatoses; Humans; Male; Photochemotherapy; Photosensitizin | 2003 |
Allergic contact dermatitis to methyl aminolevulinate after photodynamic therapy in 9 patients.
Topics: Adult; Aged; Allergens; Aminolevulinic Acid; Dermatitis, Allergic Contact; Diagnosis, Differential; | 2007 |
Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application.
Topics: Aminolevulinic Acid; Body Temperature; Carcinoma, Basal Cell; Facial Dermatoses; Facial Neoplasms; H | 1995 |
Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
Topics: Abdomen; Administration, Topical; Adult; Aged; Aminolevulinic Acid; Facial Dermatoses; Humans; Lymph | 2000 |
Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment.
Topics: Administration, Cutaneous; Adult; Aged; Aminolevulinic Acid; Clinical Trials, Phase II as Topic; Fac | 2002 |
The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Clinical Trials, Phase III | 2002 |